Related Experiment Videos
[The body's antioxidative systems in bronchopulmonary disease]
1Chita Medical Institute.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
|January 1, 1996
Summary
Patients with chronic nonspecific pulmonary diseases (CNSPD) show the greatest antioxidant deficiency. Malignant tumors impact antioxidant levels based on stage and type, suggesting resource redistribution.
Area of Science:
- Pulmonary Medicine
- Oncology
- Biochemistry
Background:
- Chronic nonspecific pulmonary diseases (CNSPD) and respiratory tumors significantly impact patient health.
- Antioxidative defense systems play a crucial role in mitigating cellular damage.
- Understanding these defense mechanisms is vital for disease management and treatment.
Purpose of the Study:
- To comprehensively analyze antioxidative defense parameters in patients with CNSPD and respiratory tumors.
- To investigate the relationship between antioxidant levels and disease characteristics.
- To explore potential shifts in antioxidative resources during tumorigenesis.
Main Methods:
- Evaluation of antioxidative defense parameters in blood and lung tissues.
- Comparison of antioxidant levels across different patient groups (CNSPD, malignant tumors, benign tumors).
- Correlation analysis of biochemical parameters in blood and lung tissue.
Main Results:
- CNSPD patients exhibited the most significant deficiency in blood and lung tissue antioxidants.
- Antioxidant levels in malignant tumor patients varied with malignancy stage and tumor histology.
- Correlations were observed between blood and lung tissue antioxidant parameters in cancer patients.
- Evidence suggests antioxidative resource redistribution in adenocarcinoma and small-cell carcinoma.
Conclusions:
- Antioxidative defense is notably compromised in CNSPD.
- Tumor malignancy and histology influence systemic antioxidant status.
- Potential redistribution of antioxidative resources occurs in specific lung cancer types, impacting therapeutic strategies.